Adjunctive Hydrocortisone Improves Hemodynamics in Critically Ill Patients with Septic Shock: An Observational Study Using Transpulmonary Thermodilution.

Septic shock is associated with high mortality and hemodynamic impairment. The use of corticoids is a common therapeutic tool in critically ill patients. However, data on the mechanisms and prognostic ability of hemodynamic improvement by adjunctive steroids are rare. This study primarily aimed to evaluate short-term effects of hydrocortisone therapy on catecholamine requirement and hemodynamics derived from transpulmonary thermodilution (TPTD) in 30 critically ill patients with septic shock and a 28 days mortality rate of 50%. Hydrocortisone was administered with an intravenous bolus of 200 mg, followed by a continuous infusion of 200 mg per 24 h. Hemodynamic assessment was performed immediately before as well as 2, 8, 16, and 24 h after the initiation of corticoids. For primary endpoint analysis, we evaluated the impact of hydrocortisone on vasopressor dependency index (VDI) and cardiac power index (CPI). Adjunctive hydrocortisone induced significant decreases of VDI from 0.41 (0.29-0.49) mmHg at baseline to 0.35 (0.25-0.46) after 2 h ( < .001), 0.24 (0.12-0.35) after 8 h ( < .001), 0.18 (0.09-0.24) after 16 h ( < .001) and 0.11 (0.06-0.20) mmHg after 24 h ( < .001). In parallel, we found an improvement in CPI from 0.63 (0.50-0.83) W/m at baseline to 0.68 (0.54-0.85) after 2 h ( = .208), 0.71 (0.60-0.90) after 8 h ( = .033), 0.82 (0.6-0.98) after 16 h ( = .004) and 0.90 (0.67-1.07) W/m after 24 h ( < .001). Our analyses revealed a significant reduction in noradrenaline requirement in parallel with a moderate increase in mean arterial pressure, systemic vascular resistance index, and cardiac index. As a secondary endpoint, our results showed a significant decrease in lung water parameters. Moreover, changes in CPI (ΔCPI) and VDI (ΔVDI) after 24 h of hydrocortisone therapy revealed accurate prognostic ability to predict 28 days mortality (AUC = 0.802 vs 0.769). Adjunctive hydrocortisone leads to a rapid decrease in catecholamine requirement and a substantial circulatory improvement in critically ill patients with septic shock.